Hence, these results indicate that HDAC inhibition can change the balance between pro- and anti-apoptotic proteins, which could explain why the combination treatment with HDAC inhibition and Bcl-2 family member inhibition is highly synergistic in chondrosarcoma cells. This evidence concerns the gene HDAC9 and chondrosarcoma.